TherapeuticsMD Inc (NYSEMKT:TXMD), which happens to be a high end innovative women’s healthcare provider has today made an announcement citing its excitement following the fact that its recent study was a great success and it brought about positive results.
The positive Phase 3 data in the two presentations for TX-001HR at ENDO 2017 is a great step towards promoting wellness among women globally and according to some of the company’s top officials, the move couldn’t have come at a better time!
The oral presentation today had the Director of the Reproductive Endocrinology Program, Rogerio Lobo, who is at the same time the M.D., professor of Obstetrics and Gynecology at Columbia University review the comprehensive findings from the Replenish Trial.
This latest study has brought to the limelight a number of important findings. The efficacy of TX-001HR has been vindicated in a big way and the company is not going to stop in its quest to develop top-notch remedies for people a round the globe.
While talking about this great recent development in the medical field, it would be unreasonable to leave out the great role the advanced technologies have played towards taking this company to the high success levels.
The current times are witnessing technological developments take off at neck-break speeds and that going hand in hand with the dedication showcased by the company’s industrious workforces have helped the company make important steps forward.
Rogerio Lobo, in making a statement expressed great excitement over the fact that the company as able to at last witness evidence from a well-controlled trial, backing up the use of well defined dosages of the bio-identical estradiol and progesterone in combination and the role they played together in the treatment of VMS.
A much closer look at the research data, and of course that refers to both the primary as well as the secondary end-points indicate a promising future for suffering patients. If TX-001HR gets approved, it will be a new dawn for all those women that have over the years struggled with the various symptoms of menopause.
